热门资讯> 正文

Sana Biotechnology通过ATM股票出售筹集6900万美元

2026-05-15 21:26

Sana Biotechnology, Inc.(SANA) 0
美国银行(BAC) 0

Sana Biotechnology (SANA) said on Friday it sold about 21.6M shares through its at-the-market facility with TD Securities, generating net proceeds of roughly $69M.
The company said the financing, together with a previously announced unrelated $25M investment from the Mayo Clinic, increased total capital raised since the end of the first quarter of 2026 to about $94M.
Sana said the funding extends its expected cash runway to mid-2027.
Stock down 4% in premarket trading.

More on Sana Biotechnology

Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey
Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript
Sana Biotechnology GAAP EPS of -$0.17 in-line
Sana Biotech rises as Mayo Clinic partners for diabetes therapy

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。